Laboratory tests of mumps vaccines

Biologicals

Volumn 25, Issue 1, 1997, Pages 35-40

  Minor, P D ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MUMPS VACCINE;

DRUG DETERMINATION; DRUG POTENCY; DRUG SAFETY; LABORATORY TEST; MOLECULAR BIOLOGY; MUMPS; MUMPS VIRUS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

MUMPS VIRUS;

EID: 0031105617     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.1997.0058     Document Type: Article

References (17)

1. 1. Peltola H. Mumps vaccination and meningitis. Lancet 1993; 341: 994-995.
2. 2. Murphy FA, Fauquet CM, Bishop DHL et al. Virus Taxonomy: Sixth report of the International Committee on Taxonomy of viruses. Archives of Virology, 1995; Suppl. 10: 268-274.
3. 3. Enders JF, Levens JH, Stokes JH et al. Attenuation of virulence with retention of antigenicity of mumps virus after passage in the embryonated egg. J Immunol 1946; 54: 283-290.
4. 4. Buynak EB and Hilleman MR. Live attenuated mumps virus vaccine. 1. Vaccine development. Proc Soc Exp Biol Med 1966; 123: 768-775.
5. 5. Yamaniski K, Takahashi M, Kuirimura T et al. Studies on live mumps virus vaccine III Evaluation of newly developed live mumps virus vaccine. Biken J 1970; 13: 151-161.
6. 6. Gluck R, Hoskins JM, Wegmann A et al. Rubini, a new live attenuated mumps vaccine virus strain for human diploid cells. Dev Biol Stand 1986; 65: 29-35.
7. 7. WHO Requirements for mumps vaccine (Live). Technical Report Series 1987; 760: 139-164.
8. 8. Levenbook IS, Nikolayeva, MA, Chirgininsky, AE et al. On the morphological evaluation of the neurovirulence safety of attenuated mumps virus strains in monkeys. J Biol Stand 1979; 7: 9-19.
9. 9. Forsey T, Heath AB and Minor PD. A European collaborative study to assess the proficiency of laboratory estimates of potency of live measles mumps and rubella trivalent vaccines. Biologicals 1993; 21: 239-249.
10. 10. Forsey T, Mawn JA, Yates PJ et al. Differentiation of vaccine and wild mumps viruses using the polymerase chain reaction and dideoxynucleotide sequencing. J Gen Virol. 1990; 71: 987-990.
11. 11. Yamada A, Takeuchi K, Tanabayashi K et al. Differentiation of the mumps vaccine strains from the wild viruses by the nucleotide sequences of the P gene. Vaccine 1990; 8: 553-557.
12. 12. Brown EG, Furesz J, Dimmock K et al. Nucleotide sequence analysis of Urabe mumps vaccine strain that caused meningitis in vaccine recipients. Vaccine 1991; 9: 840-842.
13. 13. Colville A, Pugh M. Mumps meningitis and measles, mumps and rubella vaccine. Lancet 1992; 340: 786.
14. 14. Ueda K, Miyazaki C, Hidaka, Y et al. Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan. Lancet 1995; 346: 701-702.
15. 15. Turner PC, Forsey T and Minor PD. Comparison of the nucleotide sequence of the SH gene and flanking regions of mumps vaccine virus (Urabe strain) grown on different substrates and isolated from vaccinees. J Gen Virol 1991; 72: 435-437.
16. 16. Afzal MA, Pickford AR, Yates JP et al. Matrix protein gene sequences of vaccine and vaccine-associated strains of mumps virus. J Gen Virol 1994; 75: 1169-1172.
17. 17. Afzal MA, Pickford AR, Forsey T et al. The Jeryl Lynn vaccine strain of mumps virus is a mixture of two distinct isolates. J Gen Virol 1993; 74: 917-920.